These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28282403)

  • 41. Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors.
    Nie P; Li D; Hu L; Jin S; Yu Y; Cai Z; Shao Q; Shen J; Yi J; Xiao H; Shen L; He B
    PLoS One; 2014; 9(5):e97009. PubMed ID: 24816562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice.
    Jääskeläinen AE; Seppälä S; Kakko T; Jaakkola U; Kallio J
    Neuropeptides; 2013 Apr; 47(2):67-73. PubMed ID: 23261359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody.
    Lutgens E; Faber B; Schapira K; Evelo CT; van Haaften R; Heeneman S; Cleutjens KB; Bijnens AP; Beckers L; Porter JG; Mackay CR; Rennert P; Bailly V; Jarpe M; Dolinski B; Koteliansky V; de Fougerolles T; Daemen MJ
    Circulation; 2005 Jun; 111(25):3443-52. PubMed ID: 15967845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.
    Combadière C; Potteaux S; Gao JL; Esposito B; Casanova S; Lee EJ; Debré P; Tedgui A; Murphy PM; Mallat Z
    Circulation; 2003 Feb; 107(7):1009-16. PubMed ID: 12600915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice.
    Dawson TC; Kuziel WA; Osahar TA; Maeda N
    Atherosclerosis; 1999 Mar; 143(1):205-11. PubMed ID: 10208497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
    Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adiponectin improves NF-κB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice.
    Wang X; Chen Q; Pu H; Wei Q; Duan M; Zhang C; Jiang T; Shou X; Zhang J; Yang Y
    Lipids Health Dis; 2016 Feb; 15():33. PubMed ID: 26965176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice.
    Braunersreuther V; Steffens S; Arnaud C; Pelli G; Burger F; Proudfoot A; Mach F
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1090-6. PubMed ID: 18388327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
    Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.
    Papadopoulos P; Bousette N; Al-Ramli W; You Z; Behm DJ; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Atherosclerosis; 2009 Jun; 204(2):395-404. PubMed ID: 19111831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Practical assessment of the quantification of atherosclerotic lesions in apoE⁻/⁻ mice.
    Lin Y; Bai L; Chen Y; Zhu N; Bai Y; Li Q; Zhao S; Fan J; Liu E
    Mol Med Rep; 2015 Oct; 12(4):5298-306. PubMed ID: 26239265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Ng CJ; Bourquard N; Hama SY; Shih D; Grijalva VR; Navab M; Fogelman AM; Reddy ST
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1368-74. PubMed ID: 17446441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Everolimus limits aortic aneurysm in the apolipoprotein E-deficient mouse by downregulating C-C chemokine receptor 2 positive monocytes.
    Moran CS; Jose RJ; Moxon JV; Roomberg A; Norman PE; Rush C; Körner H; Golledge J
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):814-21. PubMed ID: 23393391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.
    Borst O; Schaub M; Walker B; Schmid E; Münzer P; Voelkl J; Alesutan I; Rodríguez JM; Vogel S; Schoenberger T; Metzger K; Rath D; Umbach A; Kuhl D; Müller II; Seizer P; Geisler T; Gawaz M; Lang F
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):547-57. PubMed ID: 25614279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice.
    Koenen RR; von Hundelshausen P; Nesmelova IV; Zernecke A; Liehn EA; Sarabi A; Kramp BK; Piccinini AM; Paludan SR; Kowalska MA; Kungl AJ; Hackeng TM; Mayo KH; Weber C
    Nat Med; 2009 Jan; 15(1):97-103. PubMed ID: 19122657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis.
    Keul P; Lucke S; von Wnuck Lipinski K; Bode C; Gräler M; Heusch G; Levkau B
    Circ Res; 2011 Feb; 108(3):314-23. PubMed ID: 21164103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice.
    Ervinna N; Mita T; Yasunari E; Azuma K; Tanaka R; Fujimura S; Sukmawati D; Nomiyama T; Kanazawa A; Kawamori R; Fujitani Y; Watada H
    Endocrinology; 2013 Mar; 154(3):1260-70. PubMed ID: 23337530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.